Global Renal Biomarker Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Renal Biomarker Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Renal Biomarker Market Size Growth Rate by Product
- 1.4.2 Functional Biomarker
- 1.4.3 Up-Regulated Proteins
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Renal Biomarker Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Diagnostic Labs
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Renal Biomarker Market Size
- 2.1.1 Global Renal Biomarker Revenue 2014-2025
- 2.1.2 Global Renal Biomarker Sales 2014-2025
- 2.2 Renal Biomarker Growth Rate by Regions
- 2.2.1 Global Renal Biomarker Sales by Regions
- 2.2.2 Global Renal Biomarker Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Renal Biomarker Sales by Manufacturers
- 3.1.1 Renal Biomarker Sales by Manufacturers
- 3.1.2 Renal Biomarker Sales Market Share by Manufacturers
- 3.1.3 Global Renal Biomarker Market Concentration Ratio (CR5 and HHI)
- 3.2 Renal Biomarker Revenue by Manufacturers
- 3.2.1 Renal Biomarker Revenue by Manufacturers (2014-2019)
- 3.2.2 Renal Biomarker Revenue Share by Manufacturers (2014-2019)
- 3.3 Renal Biomarker Price by Manufacturers
- 3.4 Renal Biomarker Manufacturing Base Distribution, Product Types
- 3.4.1 Renal Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Renal Biomarker Product Type
- 3.4.3 Date of International Manufacturers Enter into Renal Biomarker Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Renal Biomarker Sales by Product
- 4.2 Global Renal Biomarker Revenue by Product
- 4.3 Renal Biomarker Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Renal Biomarker Breakdown Data by End User
6 North America
- 6.1 North America Renal Biomarker by Countries
- 6.1.1 North America Renal Biomarker Sales by Countries
- 6.1.2 North America Renal Biomarker Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Renal Biomarker by Product
- 6.3 North America Renal Biomarker by End User
7 Europe
- 7.1 Europe Renal Biomarker by Countries
- 7.1.1 Europe Renal Biomarker Sales by Countries
- 7.1.2 Europe Renal Biomarker Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Renal Biomarker by Product
- 7.3 Europe Renal Biomarker by End User
8 Asia Pacific
- 8.1 Asia Pacific Renal Biomarker by Countries
- 8.1.1 Asia Pacific Renal Biomarker Sales by Countries
- 8.1.2 Asia Pacific Renal Biomarker Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Renal Biomarker by Product
- 8.3 Asia Pacific Renal Biomarker by End User
9 Central & South America
- 9.1 Central & South America Renal Biomarker by Countries
- 9.1.1 Central & South America Renal Biomarker Sales by Countries
- 9.1.2 Central & South America Renal Biomarker Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Renal Biomarker by Product
- 9.3 Central & South America Renal Biomarker by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Renal Biomarker by Countries
- 10.1.1 Middle East and Africa Renal Biomarker Sales by Countries
- 10.1.2 Middle East and Africa Renal Biomarker Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Renal Biomarker by Product
- 10.3 Middle East and Africa Renal Biomarker by End User
11 Company Profiles
- 11.1 Beckman Coulter (Danaher)
- 11.1.1 Beckman Coulter (Danaher) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Beckman Coulter (Danaher) Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Beckman Coulter (Danaher) Renal Biomarker Products Offered
- 11.1.5 Beckman Coulter (Danaher) Recent Development
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Thermo Fisher Scientific Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Thermo Fisher Scientific Renal Biomarker Products Offered
- 11.2.5 Thermo Fisher Scientific Recent Development
- 11.3 Abbott Laboratories
- 11.3.1 Abbott Laboratories Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Abbott Laboratories Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Abbott Laboratories Renal Biomarker Products Offered
- 11.3.5 Abbott Laboratories Recent Development
- 11.4 BioPorto Diagnostics
- 11.4.1 BioPorto Diagnostics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BioPorto Diagnostics Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BioPorto Diagnostics Renal Biomarker Products Offered
- 11.4.5 BioPorto Diagnostics Recent Development
- 11.5 Astute Medical
- 11.5.1 Astute Medical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Astute Medical Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Astute Medical Renal Biomarker Products Offered
- 11.5.5 Astute Medical Recent Development
- 11.6 Randox Laboratories
- 11.6.1 Randox Laboratories Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Randox Laboratories Renal Biomarker Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Randox Laboratories Renal Biomarker Products Offered
- 11.6.5 Randox Laboratories Recent Development
12 Future Forecast
- 12.1 Renal Biomarker Market Forecast by Regions
- 12.1.1 Global Renal Biomarker Sales Forecast by Regions 2019-2025
- 12.1.2 Global Renal Biomarker Revenue Forecast by Regions 2019-2025
- 12.2 Renal Biomarker Market Forecast by Product
- 12.2.1 Global Renal Biomarker Sales Forecast by Product 2019-2025
- 12.2.2 Global Renal Biomarker Revenue Forecast by Product 2019-2025
- 12.3 Renal Biomarker Market Forecast by End User
- 12.4 North America Renal Biomarker Forecast
- 12.5 Europe Renal Biomarker Forecast
- 12.6 Asia Pacific Renal Biomarker Forecast
- 12.7 Central & South America Renal Biomarker Forecast
- 12.8 Middle East and Africa Renal Biomarker Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Renal Biomarker Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Renal Biomarker market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Renal Biomarker market based on company, product type, end user and key regions.
This report studies the global market size of Renal Biomarker in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Renal Biomarker in these regions.
This research report categorizes the global Renal Biomarker market by top players/brands, region, type and end user. This report also studies the global Renal Biomarker market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Beckman Coulter (Danaher)
Thermo Fisher Scientific
Abbott Laboratories
BioPorto Diagnostics
Astute Medical
Randox Laboratories
Market size by Product
Functional Biomarker
Up-Regulated Proteins
Others
Market size by End User
Hospitals
Diagnostic Labs
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Renal Biomarker market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Renal Biomarker market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Renal Biomarker companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Renal Biomarker submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Renal Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Renal Biomarker market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.